The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.

R09b, for the treatment of Primary Parkinson’s Disease (PD), has received Fast Track Designation (FTD) from the U.S. Food and ...

Hybrid, decentralized trial of bezisterim in early Parkinson's Disease prioritizes patient access and participationCARSON CITY, Nev., June ...

Can exercise slow, or even reverse, brain damage from Parkinson’s disease? Plus, hope on the horizon for patients living with ...

Apr. 14, 2025 — A groundbreaking open-source computer program uses artificial intelligence to analyze videos of patients with Parkinson's disease and other movement disorders.

Students and staff at the University of Wisconsin-Eau Claire are working on vibrating gloves to reduce symptoms of ...

Parse Biosciences today announced their commitment to support researchers from the Icahn School of Medicine at Mount Sinai in generating one of the largest single cell datasets focused on ...

SUNRISE-PD is a Phase 2b, multicenter, randomized, double-blind, placebo-controlled trial with a hybrid decentralized design that will last 20 weeks from the initial screening phase to the safety ...

Discover the importance of vital statistics for a healthy society, India's role in chemotherapy drugs, and unresolved Covid ...

Morten Harket, who for more than 40 years has been the frontman of the Grammy-nominated Norwegian pop trio a-ha, confirmed this week that he has Parkinson’s disease. Jordi Vidal/Redferns / Getty ...